Senate health committee chair Bernie Sanders has called a vote to subpoena the chief of Novo Nordisk’s U.S. division over the company’s pricing of Ozempic and Wegovy.
If the prices are as legitimate as you suggest then surely that will be easily revealed by the subpoena’d accounting books and Novo Nordisk will be cleared of suspicion. Wouldn’t that be the system working as intended?
If the prices are as legitimate as you suggest then surely that will be easily revealed by the subpoena’d accounting books and Novo Nordisk will be cleared of suspicion. Wouldn’t that be the system working as intended?
Oh yes, I’m not against Bernie doing this, but I wouldn’t call it the system working as intended, that it’s necessary.